Nuclear envelope-localized EGF family protein amphiregulin activates breast cancer cell migration in an EGF-like domain independent manner

Biochemical and Biophysical Research Communications

Volumn 420, Issue 4, 2012, Pages 721-726

  Tanaka, Hisae ^a   Nishioka, Yu ^a   Yokoyama, Yuhki ^a   Higashiyama, Shigeki ^b   Matsuura, Nariaki ^a   Matsuura, Shuji ^a   Hieda, Miki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY   (Japan)

Author keywords

Amphiregulin; Breast cancer cells; Cell migration; EGF family

Indexed keywords

AMPHIREGULIN; EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL MIGRATION; CELL NUCLEUS MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

BREAST NEOPLASMS; CELL MOVEMENT; EPIDERMAL GROWTH FACTOR; FEMALE; GLYCOPROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NUCLEAR ENVELOPE; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, EPIDERMAL GROWTH FACTOR; SEQUENCE DELETION;

EID: 84859839239     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.03.045     Document Type: Article

References (27)

1. Higashiyama S., Iwabuki H., Morimoto C., Hieda M., M, Inoue H., Matsushita N. Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands. Cancer Sci. 2008, 99:214-220.
2. Schneider S.R., Wolf E. The epidermal growth factor receptor ligands at a glance. J. Cell Physiol. 2009, 218:460-466.
3. Hieda M., Isokane M., Koizumi M., Higashi C., Tachibana T., Shudou M., Taguchi T., Hieda Y., Higashiyama S. Membrane-anchored growth factor, HB-EGF, on the cell surface targeted to the inner nuclear membrane. J. Cell Biol. 2008, 180:763-769.
4. Nanba D., Mammoto A., Hashimoto K., Higashiyama S. Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF. J. Cell Biol. 2003, 163:489-502.
5. Kinugasa Y., Hieda M., Hori M., Higashiyama S. The carboxyl-terminal fragment of pro-HB-EGF reverses Bcl6-mediated gene repression. J. Biol. Chem. 2007, 282:14797-14806.
6. Isokane M., Hieda M., Hirakawa S., Shudou M., Nakashiro K., Hashimoto K., Hamakawa H., Higashiyama S. The PM-anchored growth factor, pro-amphiregulin, binds A-type lamin and regulates global transcription. J. Cell Sci. 2008, 121:3608-3618.
7. Shoyab M., McDonald V.L., Bradley J.G., Todaro G.J. Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF7. Proc. Natl. Acad. Sci. USA 1988, 85:6528-6532.
8. Shoyab M., Plowman G.D., McDonald V.L., Bradley J.G., Todaro G.J. Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science 1989, 243:1074-1076.
9. Plowman G.D., Green J.M., McDonald V.L., Neubauer M.G., Disteche C.M., Todaro G.J., Shoyab M. The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity. Mol. Cell Biol. 1990, 10:1969-1981.
10. Ciarloni L., Mallepell S., Brisken C. AR is an essential mediator of estrogen receptor alpha function in mammary gland development. Proc. Natl. Acad. Sci. USA 2007, 104:5455-5460.
11. McBryan J., Howlin J., Napoletano S., Martin F. Amphiregulin: role in mammary gland development and breast cancer. J. Mammary Gland Biol. Neoplasia 2008, 13:159-169.
12. Willmarth N.E., Ethier S.P. Amphiregulin as a novel target for breast cancer therapy. J. Mammary Gland Biol. Neoplasia 2008, 13:171-179.
13. Ma L., Gauville C., Berthois Y., Degeorges A., Millot G., Martin P.M., Calvo F. Role of epidermal-growth-factor receptor in tumor progression in transformed human mammary epithelial cells. Int. J. Cancer 1998, 78:112-119.
14. Ma L., Gauville C., Berthois Y., Millot G., Johnson G.R., Calvo F. Antisense expression for amphiregulin suppresses tumorigenicity of a transformed human breast epithelial cell line. Oncogene 1999, 18:6513-6520.
15. Kimura H., Hayashi-Takanaka Y., Goto Y., Takizawa N., Nozaki N. The organization of histone H3 modifications as revealed by a panel of specific monoclonal antibodies. Cell Struct. Funct. 2008, 33:61-73.
16. LeJeune S., Leek R., Horak E., Plowman G., Greenall M., Harris A.L. Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer. Cancer Res. 1993, 53:3597-3602.
17. Li S., Plowman G.D., Buckley S.D., Shipley G.D. Heparin inhibition of autonomous growth implicates amphiregulin as an autocrine growth factor for normal human mammary epithelial cells. J. Cell Physiol. 1992, 153:103-111.
18. Busser B., Sancey L., Brambilla E., Coll J., Hurbin A. The multiple roles of amphiregulin in human cancer. Biochim. Biophys. Acta 2011, 1816:119-131.
19. Hirata M., Umata T., Takahashi T., Ohnuma M., Miura Y., Iwamoto R., Mekada E. Identification of serum factor inducing ectodomain shedding of proHB-EGF and studies of noncleavable mutants of proHB-EGF. Biochem. Biophys. Res. Commun. 2001, 283:915-922.
20. Rae J.M., Scheys J.O., Clark K.M., Chadwick R.B., Kiefer M.C., Lippman M.E. EGFR and EGFRvIII expression in primary breast cancer and cell lines. Breast Cancer Res. Treat. 2004, 87:87-95.
21. Gerlitz G., Livnat I., Ziv C., Yarden O., Bustin M., Reiner O. Migration cues induce chromatin alterations. Traffic 2007, 8:1521-1529.
22. Gerlitz G., Bustin M. Efficient cell migration requires global chromatin condensation. J. Cell Sci. 2010, 123:2207-2217.
23. Seki Y., Yamaji M., Yabuta Y., Sano M., Shigeta M., Matsui Y., Saga Y., Tachibana M., Shinkai Y., Saitou M. Cellular dynamics associated with the genome-wide epigenetic reprogramming in migrating primordial germ cells in mice. Development 2007, 134:2627-2638.
24. Gerlitz G., Bustin M. The role of chromatin structure in cell migration. Trends Cell Biol. 2011, 21:6-11.
25. Crisp M., Liu Q., Roux K., Rattner J.B., Shanahan C., Burke B., Stahl P.D., Hodzic D. Coupling of the nucleus and cytoplasm: role of the LINC complex. J. Cell Biol. 2005, 172:41-53.
26. Brown C.L., Meise K.S., Plowman G.D., Coffey R.J., Dempsey P.J. Cell surface ectodomain cleavage of human AR precursor is sensitive to a metalloprotease inhibitor. Release of a predominant N-glycosylated 43-kDa soluble form. J. Biol. Chem. 1998, 273:17258-17268.
27. Iborra F.J., Jackson D.A., Cook P.R. The path of transcripts from extranucleolar synthetic sites to nuclear pores: transcripts in transit are concentrated in discrete structures containing SR proteins. J. Cell Sci. 1998, 111:2269-2282.